Skip to main content
SpringerLink
Log in
Book cover

Neuro-Psychopharmaka pp 557–577Cite as

Psychopharmakotherapie von Eßstörungen

  • Chapter

  • 40 Accesses

Zusammenfassung

In den letzten beiden Dekaden haben Magersucht und insbesondere bulimische Eßstörungen allem Anschein nach beträchtlich an Häufigkeit zugenommen. Die Prävalenz liegt für Mädchen und Frauen im Risikoalter zwischen 15 und 35 Jahre für Magersucht bei 1% und für Bulimia nervosa bei 1-3%, je nach Festlegung der diagnostischen Kriterien (Szmukler 1985, Fairburn und Begun 1990). Beide Eßstörungen kommen ganz überwiegend, aber nicht ausschließlich, beim weiblichen Geschlecht vor — die Relation Frauen zu Männer beträgt etwa 12:1 (Fighter 1989). Nach den diagnostischen Kriterien nach DSM III-R (American Psychiatric Association 1987) ist Bulimia nervosa im wesentlichen definiert durch das Vorliegen wiederholter Episoden von „Freßanfällen“ (mindestens zweimal pro Woche über drei Monate), das Gefühl, das Eßverhalten während der „Freßanfälle” nicht in Kontrolle halten zu können, das Vorliegen von Maßnahmen, die einer Gewichtszunahme entgegensteuern (z.B. Erbrechen, Fasten, Diät) und eine andauernde übertriebene Beschäftigung mit Figur und Gewicht. Anorexia nervosa ist nach diesen Kriterien definiert durch ein Untergewicht von mindestens 15%, starker Angst vor Gewichtszunahme und dem Dickwerden, Körperschemastörungen und (bei Frauen) Amenorrhö.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Agras WS, Dorian B, Kirkley BG, Anrow B, Bachman J (1987) Imipramine in the treatment of bulimia: a double-blind controled study. Int J Eating Dis 6: 29–38

    Article  Google Scholar 

  • Alger SA, Schwalberg MD, Bigaouette JM (1991) Effect of tricyclic antidepressant and opiate antagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects. Am J Clin Nutr 53: 865– 871

    PubMed  CAS  Google Scholar 

  • American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders — revision (DSM I II ). APA, Washington DC

    Google Scholar 

  • American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd ed (DSM-III-R). APA, Washington DC

    Google Scholar 

  • Baranowska B, Rozbicka G, Jeske W, Abdec-FatiahMH (1984) The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of NAl+oxone on LH, follicle-stimulating hormone, prolactin and beta endorphin secretion. J Clin Endocrinol Metab 59: 412– 416

    Article  PubMed  CAS  Google Scholar 

  • Barlow J, Blouin J, Blouin A (1988) Treatment of bulimia with desipramine. A double-blind crossover study. Can J Psychiatry 330: 129–133

    Google Scholar 

  • Benady DR (1970) Cyproheptadine hydrochloride (periatin) and anorexia nervosa: a case report. Br J Psychiatry 117: 681– 682

    Article  PubMed  CAS  Google Scholar 

  • Bieck PR (1989) Hypertensive Krisen unter reversiblen Hemmstoffen des Monoaminoxidase? Ergebnisse von Tyramin-Interaktionsstudien. Psychiat Prax 16 [Suppl]: 25–31

    Google Scholar 

  • Biederman J, Herzog DB, Rivinus TM, Harper GP, Ferber RA, Rosenbaum JF, Harmatz JS, Tondorf R, Orsulak J, Schildkraut J (1985) Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study. J Clin Psychopharmacol 5 (1): 10– 16

    Article  PubMed  CAS  Google Scholar 

  • Blouin AG, Blouin JH, Perez EL, Bushnik T, Mulder E, Zuro C (1987) Bulimia treated with desipramine and fenfluramine. American Psychiatric Association Annual Meeting, Chicago (Abstract)

    Google Scholar 

  • Blouin AG, Blouin JH,Perez EL, Bushnk T, Zuro C, Mulder E (1988) Treatment of bulimia with fenfluramine and desipramine. J Clin Psychopharmacol 8: 261– 270

    Article  PubMed  CAS  Google Scholar 

  • Brotman AW, Herzog DB, Woods SW (1984) Antidepressant treatment of bulimia. The relationship between bingeing and depressive symptomatology. J Clin Psychiatry 47: 7–9

    Google Scholar 

  • Bruch H (1973) Eating disorders. Obesity, anorexia nervosa and the person within. Basic Books, New York

    Google Scholar 

  • Casper RC, Schlemmer RF, Javaid JI (1987) A placebo controlled crossover study of oral clonidine in acute anorexia nervosa. Psychiatry Res 20: 249–260

    Article  PubMed  CAS  Google Scholar 

  • Cooper PJ, Fairburn CG (1986) The depressive symptoms of bulimia nervosa. Br J Psychiatry 148: 268–274

    Article  PubMed  CAS  Google Scholar 

  • Condon JT (1986) Long-term neuroleptic therapy in chronic anorexia nervosa complicated by tardive dyskinesia. A case report. Acta Psychiatr Scand 73 (2): 203–206

    Article  PubMed  CAS  Google Scholar 

  • Craigen G, Kennedy SH, Garfinkel PE, Jeejeebhoy K (1987) Drugs that facilitate gastric emptying. In: GARFINKEL PE, GARNER DM (eds) The role of drug treatment for eating disorders. Brunner/ Mazel, New York, pp 161– 176

    Google Scholar 

  • Crisp AH, Lacey JH, Crutchfeld M (1987) Clomipramine and „drive“ in people with anorexia nervosa: an inpatient study. Br J Psychiatry 150: 355–358

    Article  PubMed  CAS  Google Scholar 

  • Dally PJ, Sargant W (1960) A new treatment of anorexia nervosa. Br Med J 1: 1770–1773

    Article  PubMed  CAS  Google Scholar 

  • Dubois A, Gross HA, Ebert MH, Castello DO (1979) Altered gastric emptying and secretion in primary anorexia nervosa. Gastroenterology 77: 319–323

    PubMed  CAS  Google Scholar 

  • Fairburn CH G (1985) Cognitive-behavioral treatment for bulimia. In: Garner DM, Garfinkel PE (eds) Handbook of psychotherapy for anorexia nervosa and bulimia. Guildorf Press, London New York, pp 160–176

    Google Scholar 

  • Fairburn CH G, Cooper PJ (1983) MAOIs in the treatment of bulimia (letter). Am J Psychiatry 40: 949–950

    Google Scholar 

  • Fairburn CF, Beglin SJ (1990) Studies of the epidemiology of bulimia nervosa. Am J Psychiatry 147: 401–408

    PubMed  CAS  Google Scholar 

  • Fairburn CH G, Cooper PJ, Kirk J, Connor M (1985) The significance of the neurotic symptoms of bulimianervosa. J Psychiatr Res 19: 135–140

    Article  PubMed  CAS  Google Scholar 

  • Ferguson JM (1987) Treatment of an anorexia nervosa patient with fluoxetine. Am J Psychiatry 144: 1239–1240

    PubMed  CAS  Google Scholar 

  • Fighter MM (1985) Magersucht und Bulimia. Springer, Berlin Heidelberg New York Tokyo

    Book  Google Scholar 

  • Fighter MM (1989) (Hrsg) Bulimia nervosa: Grundlagen und Behandlung. Enke, Stuttgart

    Google Scholar 

  • Fighter MM (1993) Die medikamentöse Behandlung von Anorexia und Bulimia nervosa — eine Übersicht. Nervenarzt 64: 21 –35

    Google Scholar 

  • Fighter MM, Noegel R (1990) Concordance for bulimia nervosa in twins. Int J Eating Dis 9: 255–263

    Article  Google Scholar 

  • Fighter MM, Prike KM, Holsboer F (1986) Weight loss causes neuroendocrine disturbances. Experimental study in healthy starving subjects. Psychiatry Res 17: 61

    Google Scholar 

  • Fighter MM, Leibl C, Brunner E, Schmidt-Auberger S, Engel RR (1990) Fluoxetine vs. Placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy. Pharmacopsychiatry 24: 1–7

    Article  Google Scholar 

  • Fighter MM, Leibl C, Rief W, Brunner E, Schmidtauberger S, Schulze-Solle, Englel R (1991) Fluoxetine versus placebo: a double-blind study with inpatients receiving intensive psychotherapy. Pharmacopsychiatry 214: 1–7

    Google Scholar 

  • Fighter MM, Quadflieg N, Rief W (1992) The german longtudinal bulimia nervosa study I. In: HERZOG W et al. (eds) The course of eating disorders. Springer, Berlin Heidelberg New York Tokyo, pp 133–149

    Chapter  Google Scholar 

  • Fluoxetine Bulimia Collaborative Study Group. Levine LR, Pope HG, Enas GG, Ballenger JC, Blinder BJ, Dixon K, Dunlop SR, Goldbloom DS, Ferguson JM, Halikas J, Herzog DB, Hsu LKG, Hudson JI, Powers PS, Reinher FW, Yates WR (1992) Fluoxetine in the treatment of bulimia nervosa: a multicenter placebo-controlled double-blind trial. Arch Gen Psychiatry 49: 137–139

    Google Scholar 

  • Frahm J (1966) Beschreibung and Ergebnisse einer somatisch orientierten Behandlung von Kranken mit Anorexia Nervosa. Med Wochenschr 17: 2004–2074

    Google Scholar 

  • Freeman CPL, Gardiner H, Jessainger DK Collins SA. Fluvoxamine, an open pilot study in moderately obese, female patients suffering from atypical eating disorders and episodes of bingeing (unpublished)

    Google Scholar 

  • Freeman CPL, Davies F, Morris J, Cheshire K, Hampson M (1993) A double-blind controlled trial of fluoxetine versus placebo for bulimia nervosa. Br J Psychiatry (in press)

    Google Scholar 

  • Gershon ES, Schreiber JL, Hamovit JR, Dibble ED, Kaye WH (1984) Clinical findings in patients with anorexia nervosa and affective illness in their key relatives. Am J Psychiatry 141: 1419–1422

    PubMed  CAS  Google Scholar 

  • Goldberg SC, Halmi KA, Eckert ED (1979) CypIoheptadine in anorexia nervosa. Br J Psychiatry 346: 67–70

    Article  Google Scholar 

  • Griffith R, Touyz SW, Mitchell BP, Bacon W (1987) The treatment of bulimia nervosa: a review. Aust N Z J Psychiatry 21: 5–15

    Article  Google Scholar 

  • Gross H, Ebert MH, Faden VB (1981) A double-blind controlled trial of lithium carbonate in primary anorexia nervosa. J Clin Psychopharmacol 1: 376–381

    Article  PubMed  CAS  Google Scholar 

  • Gross HA, Ebert MH, Faden VB, Goldberg SY, Kaye WH (1983) A double-blind trial of delta 9-tetrahydro-Cannabinol in primary anorexia nervosa. J Clin Psychopharmacol 3: 165–171

    Article  PubMed  CAS  Google Scholar 

  • Gwirtsman HE, Guze BH, Yager J, Gainsley B (1990) Fluoxetine treatment of anorexia nervosa: an open clinical trial. J Clin Psychiatry 51: 378–382

    PubMed  CAS  Google Scholar 

  • Halmi KA, Eckert E, Falk JR (1982) Cyproheptadine for anorexia nervosa. Lancet is 1357 –1358

    Google Scholar 

  • Halmi KA, Owen WP, Lasley E, Stokes P (1983) Dopaminergic regulation in anorexia nervosa. Int J Eating Disord 2 /4: 129–133

    Article  Google Scholar 

  • Haölmi KA, Eckert E, Ladu TJ, Cohen J (1986) Anorexia nervosa. Treatment efficacy of cyproheptadine and amitriptyline. Arch Gen Psychiatry 43: 177–181

    Article  Google Scholar 

  • Harrower ADB, Yap PL, Nairn JM, Walton HJ, Srong JA (1977) Growth hormone, insulin, prolactin secretion in anorexia nervosa and obesity during bromocriptine treatment. Br Med J 2: 156–159

    Article  PubMed  CAS  Google Scholar 

  • Hawthorne ME, Lacey JH (1992) Severe disturbance occurring during treatment for depression of a bulimic patient with fluoxetine. J Affect Dis 26: 205–208

    Article  PubMed  CAS  Google Scholar 

  • Hoes M (1980) Coppersulphate and pimozide for anorexia nervosa. J Orthomol Psychiatry 9 (1): 48–51

    Google Scholar 

  • Horne RL, Ferguson JM, Pope HG (1988) Treatment of bulimia with bupropion. A multicenter controlled trial. J Clin Psychiatry 49: 262–266

    PubMed  CAS  Google Scholar 

  • How J, Davidson RJL (1977) Chlorpromazine induced haemolytic anaemia in anorexia nervosa. Postgrad Med J 53 (619): 278–279

    Article  PubMed  CAS  Google Scholar 

  • hsu LKG (1984) Treatment of bulimia with lithium. Am J Psychiatry 141: 1260–1262

    PubMed  CAS  Google Scholar 

  • Hsu LKG, Clement L, Santhouse R (1987) Treatment of bulimia with lithium. A preliminary study. Psychopharmacol Bull 23: 45–48

    PubMed  CAS  Google Scholar 

  • Hudson JI, Pope HG (1990a) Psychopharmacological treatment of bulimia. In: Fichter MM (ed) Bulimia nervosa: basic research, diagnosis and therapy. Wiley, Chichester, pp 331–342

    Google Scholar 

  • Hudson JI, Pope HG (1990b) Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology? Am J Psychiatry 147: 552– 564

    CAS  Google Scholar 

  • Hudson JI, Pope HG JR, Joans JM, Yurgelun-ToddD (1983) Phenomenologic relationship of eating disorders to major affective disorder. Psychiatry Res 9: 345–354

    Article  PubMed  CAS  Google Scholar 

  • Hudson JI, Pope HG JR, Jonas JM, Yurgelun-Todd D (1985) Treatment of anorexia nervosa with antidepressants. J Clin Psychopharmacol 5 (1): 17–23

    Article  PubMed  CAS  Google Scholar 

  • Hudson JI, Pope HG, Keck PE, Mc Elroy S (1989) Treatment of bulimia nervosa with trazodone: short-term response and long-term follow-up. Clin Neuropharmacol 12 (1): 38–46

    Article  Google Scholar 

  • Hughes PL, Wells LA, Cunningham CJ, Ilstrup DM (1986) Treatment bulimia with desipramine: a placebo-controlled double-blind study. Arch Gen Psychiatry 43: 182–186

    Article  PubMed  CAS  Google Scholar 

  • Igoin-ApfelbaumL, Apfelbaum M (1987) Naltrexone and bulimic symptoms ( Letter ). Lancet ii: 1087–1088

    Google Scholar 

  • Jonas JM, Gold MS (1986) Naltrexone reverses bulimic symptoms. Lancet is 807

    Google Scholar 

  • Jonas JM, Gold MS (1987) Treatment of antidepressant-resistant bulimia with naltrexone. Int J Psychiatry Med 16: 305–309

    Article  CAS  Google Scholar 

  • Kaplan AS (1987) Anticonvulsant treatment of eating disorders. In: Garfinkel PE, Garner DM (eds) The role of drug treatments for eating disorders. Brunner/Mazel, New York, pp 96–123

    Google Scholar 

  • Kaplan AS, Garfinkel PE, Garner DM (1987) Bulimia treated with carbamazepine and imipramine. American Psychiatric Association Annual Meeting, Chicago (Abstract )

    Google Scholar 

  • Kaye WH, Pickar D, Naber D, Ebert MH (1982) Cerebrospinal fluid activity in anorexia nervosa. Am J Psychiatry 139: 643–645

    PubMed  CAS  Google Scholar 

  • Kennedy SH, Piran N, Garfinkel PE (1985) Monoamine oxidase inhibitor therapy for anorexia nervosa and bulimia: a preliminary trial of isocarboxazid. J Clin Psychopharmacol 5: 279–285

    Article  PubMed  CAS  Google Scholar 

  • Kennedy SH, Piran N, Warsh RR, Prendergast P, Mainprize E, Whynot C, Garfinkel PE (1988) A trial of isocarboxazid in the treatment of bulimia. J Clin Psychopharmacol

    Google Scholar 

  • Kennedy SH, Goldbloom DS, D’Souza J, Lofchy J (1991) Brofaromine - a selective MAO-Inhibitor in bulimia nervosa. 5th World Congress of Biological Psychiatry, Florence (Abstract)

    Google Scholar 

  • Krahn D, Mitchel J (1985) Use of L-Tryptophan in treating bulimia. Am J Psychiatry 142: 1130

    PubMed  CAS  Google Scholar 

  • Lacey JH, Crisp AH (1980) Hunger, food intake and weight: the impact of clomipramine on a receding anorexia nervosa population. Postgrad Med J 56: 79 –85

    PubMed  Google Scholar 

  • Liebowitz SF (1983) Hypothalamic catecholamine systems controlling eating behavior: a potential model for anorexia nervosa. In: Darby PL et al. (eds) Anorexia nervosa: recent developments in research. Alan R Liss, New York, pp 221–229

    Google Scholar 

  • Marcus MD, Wing RR, Ewing L, Kern E, Mcdermott M, Gooding W (1990) A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and non-binge-eaters. Am J Psychiatry 147 (7): 877–881

    Google Scholar 

  • Mills IH (1973) Endocrine and social factors in self-starvation amenorrhea. In: Robertson RF, Proudfoot AT (eds) Anorexia nervosa and ebesity. Royal College of Physicians of Edinburgh, Edinburgh, pp 31–43

    Google Scholar 

  • mitchell JE, groat R (1984) A placebo-controlled, double-blind trial of amitriptyline in bulimia. J Clin Psychopharmacol 4: 186–193

    Article  PubMed  CAS  Google Scholar 

  • Mitchell JE, Hosfield N, Pyle R (1983) EEG findings in patients with the bulimia syndrome. Int J Eating Disord 2: 17–21

    Article  Google Scholar 

  • Mitchell JE, Lkaine DE, Morley JE, Levine AS (1986) Naloxone but not CCK-8 may attenuate binge-eating behavior in patients with the bulimia-syndrome. Biol Psychiatry 21: 1399–1406

    Article  PubMed  CAS  Google Scholar 

  • Mitchell JE, Pyle RL, Eckert ED, Hatsukami D, Pomeroy C (1988) Preliminary results of a comparison treatment trial of bulimia nervosa. In: Pirke KM, Vandereycken W, Ploog D (eds) The psychobiology of bulimia nervosa. Springer, Berlin Heidelberg New York Tokyo, pp 152–157

    Chapter  Google Scholar 

  • Mitchell JE, Christenson G, Jennings J, Huber M, Thomas B (1989a) A placebo controlled double blind crossover study of maltrexone hydrochloride in outpatients with normal weight bulimia. J Clin Psychopharmacol 9: 94–97

    Article  PubMed  CAS  Google Scholar 

  • Mitchell JE, Pyle RL, Eckert ED, Hatsukami D, Pomeroy C, Zimmerman R (1989b) Response to alternative antidepressants in imipramine nonresponders with bulimia nervosa. J Clin Psychopharmacol 9 (4): 291–293

    Article  PubMed  CAS  Google Scholar 

  • Mitchell JE, Pyle RL, Eckert ED, Hatsukami D, Pomeroy C (1990) A comparison study of antidepressant and structured intensive group psychotherapy in the treatment of bulimia nervosa. Arch Gen Psychiatry 47: 149–157

    Article  PubMed  CAS  Google Scholar 

  • Mitchell JE, Morley JE, Levine AS, Hatsukami D, Gannon M, Pfohl D (1993) High dose naltrexone therapy combined with dietary counseling in the treatment of obesity. Biol Psychiatry (in press)

    Google Scholar 

  • Moldofsky H, Jeuniewic N, Garfinkel PJ (1977) Preliminary report of metoclopramide in anorexia nervosa. In: Vigersky RA (ed) Anorexia nervosa. Raven Press, New York, pp 373–376

    Google Scholar 

  • Moore R, Mills JH (1981) Naloxone in the treatment of anorexia nervosa. Effect on weight gain and lipolysis. J Proc Roy Soc Med 74: 129–131

    CAS  Google Scholar 

  • Murphy DL, Siever LJ, Insel TR (1985) Therapeutic responses to tricyclic antidepressants and related drugs in non-affective disorder patient populations. Prog Neuropsychopharmacol Biol Psychiatry (Oxford) 9: 3–13

    Article  CAS  Google Scholar 

  • Needelman HL, Waber D (1976) Amitriptylin therapy in patients with anorexia nervosa. Lancet 42: 471

    Google Scholar 

  • Pope HG JR, Hudson JI, Jonas JM, Yurgelun-Todd (1983) Bulimia treated with imipramine. A placebo-controlled, double-blind study. Am J Psychiatry 140: 554–558

    PubMed  Google Scholar 

  • Pope HG JR. Hudson JI, Jonas JM, Yurgelun-Todd D (1985) Antidepressant treatment of bulimia: a two-year follow-up study. J Clin Psychopharmacol 5,6: 320–327

    PubMed  Google Scholar 

  • Pope HG JR, Keck PE, Mcelroy SL (1989) A place- bo-controlled study of trazodone in bulimia nervosa. J Clin Psychopharmacol 5: 320–327

    Google Scholar 

  • Pope HG, Mcelroy SL, Keck PE, Hudson JI, Fer- Guson JM, Horne RL (1989) Electrophysiologicabnormalities in bulimia and their implications for pharmacotherapy: a reassessment. Int Eating Disord 8 (2): 191–201

    Article  Google Scholar 

  • Price WA, Babai MR (1987) Antidepressant drug therapy for bulimia (letter). J Clin Psychiatry 48: 385

    PubMed  CAS  Google Scholar 

  • Rigaud D,Bedig G,Merrouche M,Vulpillat M, Bonfils S(1988) Delayed gastric emptying in anorexia nervosa is improved by completion of a renutrition program. Dig Dis Sci 33: 919–925

    Google Scholar 

  • Rigotti NA, Nussbaum SR, Herzog DB, Neer RM (1984) Oesteoporosis in women with anorexia nervosa. N Engl J Med 311: 1601–1606

    Article  PubMed  CAS  Google Scholar 

  • Rigotti NA, Neer RM, Skates SJ, Herzog DB, Nussbaum SR (1991) The clinical course of oesteoporosis in anorexia nervosa. A longtudinal study of cortical bone mass. JAMA 265 (9): 1133–1138

    Article  PubMed  CAS  Google Scholar 

  • Robinson PH, Checkley SA, Russell GFM (1985) Suppression of eating by fenfluramine in patients with bulimia nervosa. Br J Psychiatry 146: 169–176

    Article  PubMed  CAS  Google Scholar 

  • Robinson PH, Clarke M, Barrett J (1988) Determinations of delayed gastric emptying in anorexia nervosa and bulimia nervosa. Gut 29: 458–464

    Article  PubMed  CAS  Google Scholar 

  • Russell DMCR, Freedman ML, Feiglin DHI (1983) Delayed gastric amptying and improvement with domperidone in a patient with anorexia nervosa. Am J Psychiatry 140 (9): 1235–1236

    PubMed  CAS  Google Scholar 

  • Sabine EJ, Yonace A, Farrington AJ, Barrat KH, Wakeling A (1983) Bulimia nervosa: a placebo controlled double-blind therapy trial of mianserin. Br J Clin Pharmacol 15: 195–202

    Article  Google Scholar 

  • Saleh JW, Lebwohl P (1979) Gastric emptying studies in patients with anorexia nervosa: effect of metochlopramide. Gastroenterology 76 /511: 1233

    Google Scholar 

  • Salisbury JJ, Mitchell JE (1991) Bone mineral density and anorexia nervosa in women. Am J Psychiatry 148: 768–774

    PubMed  CAS  Google Scholar 

  • Stacher G, Bergmann H, Wiesnagrotzki S, Kiss A, Hobarth J (1985) Anorexia nervosa and bulimia: delayed gastric emptying accelerated by cisapride. International Symposium on Disorders of Eating Behavior, Pavia, Italy (Abstract )

    Google Scholar 

  • Szmukler GI (1985) The epidemiology of anorexia nervosa and bulimia. J Psychiatr Res 19: 143–153

    Article  PubMed  CAS  Google Scholar 

  • Vandereycken W (1984) Neuroleptics in the short-term treatment of anorexia nervosa: a double-blind-controlled study with sulpride. Br J Psychiatry 144: 288–292

    Article  PubMed  CAS  Google Scholar 

  • Vandereycken W, Pierloot R (1982) Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa: a double-blind placebo-controlled cross-over study. Acta Psychiatr Scand 66: 445–450

    Article  PubMed  CAS  Google Scholar 

  • Vigersky RD, Loriaux DL (1977) The effect of cyproheptadine in anorexia nervosa: a double-blind trial. In: Vigersky RA (ed) Anorexia nervosa. Raven Press, New York, pp 349–356

    Google Scholar 

  • Walsh BT (1990) Persönliche Mitteilung

    Google Scholar 

  • Walsh BT (1991) Fluoxetine treatment of bulimia nervosa. J Psychosom Res 35 (1): 33 –40

    Article  PubMed  Google Scholar 

  • Walsh BT, Stewart JW, Roose SP, Gladis M, Glass-Man AH (1984) Treatment of bulimia with phenelzine: a double-blind, placebo-controlled study. Arch Gen Psychiatry 41: 1105–1109

    Article  PubMed  CAS  Google Scholar 

  • Walsh BT, Gladis M, Roose SP, Stewart JW, Stetner F, Glassman AH (1988) Phenelzine vs. placebo in 50 patients with bulimia. Arch Gen Psychiatry 45: 471–477

    Article  PubMed  CAS  Google Scholar 

  • Walsh BT, Hadigan CM, Devlin MJ, Gladis M, Roose SP (1991) Long-term outcome on antidepressant treatment for bulimia nervosa. Am J Psychiatry 148: 1206–1212

    PubMed  CAS  Google Scholar 

  • Wermuth BM, Davis KL, Hollister LE, Stunkard AJ (1977) Phenytoin treatment of the binge-eating syndrome. Am J Psychiatry 134: 1249–1253

    PubMed  CAS  Google Scholar 

  • White JH, Schmaultz NL (1977) Successful treatment of anorexia nervosa with imipramine. Dis New Syst 38: 567–568

    CAS  Google Scholar 

Download references

Authors
  1. M. M. Fichter
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinische Neurochemie, Psychiatrische Universitätsklinik, Füchsleinstraße 15, D-97080, Würzburg, Bundesrepublik Deutschland

    Peter Riederer

  2. Psychiatrische Universitätsklinik, Sigmund-Freud-Straße 25, D-53105, Bonn, Bundesrepublik Deutschland

    Gerd Laux

  3. Psychiatrische Universitätsklinik, Wilhelm Klein-Straße 27, CH-4025, Basel, Schweiz

    Walter Pöldinger

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Wien

About this chapter

Cite this chapter

Fichter, M.M. (1993). Psychopharmakotherapie von Eßstörungen. In: Riederer, P., Laux, G., Pöldinger, W. (eds) Neuro-Psychopharmaka. Springer, Vienna. https://doi.org/10.1007/978-3-7091-3317-0_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-3317-0_10

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-3318-7

  • Online ISBN: 978-3-7091-3317-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation